Maruho North America Inc.
6
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
50%
3 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Long Term Study to Evaluate Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis
Role: lead
Study to Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis
Role: lead
Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis
Role: lead
Skin Safety Study to Evaluate the Sensitizing Potential in Healthy Volunteers
Role: lead
Skin Safety Study to Evaluate the Irritation Potential in Healthy Volunteers
Role: lead
Study to Evaluate the Pharmacokinetics and the Safety of M518101 in Plaque Psoriasis Patients
Role: lead
All 6 trials loaded